1.130USD-0.88%Mkt Cap: 34.89M USDP/E: —Last update: 2026-05-22
BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immu…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.8
13.20BEURP/E 30.1
12.83BTRY—
10.85BUSD—
loading…
Indicators:|
Key Statistics
Company
Market Cap34.89M USD
Enterprise Value118.31M USD
Revenue (TTM)680.00K USD
Gross Profit478.00K USD
Net Income (TTM)-69.90M USD
Revenue/Share0.0400 USD
Last Price1.130 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS09075P1057
Valuation
P/E (Trailing)—
P/E (Forward)-0.74
PEG—
EV/EBITDA-2.36
EV/Revenue173.98
P/S51.77
P/B-0.29
EPS (TTM)-4.77
EPS (Forward)-1.54
52W Range
1.0102% of range8.080
52W High8.080 USD
52W Low1.010 USD
Profitability
Gross Margin74.45%
Oper. Margin-4962.62%
EBITDA Margin0.00%
Profit Margin-10887.38%
ROE73.22%
ROA-155.62%
Growth
Revenue Growth22.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-57.62M USD
CapEx (TTM)—
FCF Margin-5054.93%
FCF Yield-98.51%
Net Debt83.11M USD
Net Debt/EBITDA-1.66
Balance Sheet
Debt/Equity-1.15
Current Ratio0.62
Quick Ratio0.32
Book Value/Sh-3.8980 USD
Cash/Share0.5560 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:16
Split DateFeb 10, 2025
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)14.00 USD
Target Range1.000 USD – 38.00 USD
# Analysts4
Ownership
Shares Out.30.88M
Float28.11M
Insiders3.48%
Institutions18.72%
Short Interest
Short Ratio4.0d
Short % Float16.01%
Short % Out.15.67%
Shares Short4.24M
Short (prev mo.)3.31M
Technical
SMA 501.234 (-8.5%)
SMA 2002.140 (-47.2%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)761.81K
Avg Vol (10d)463.75K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—